PMID: 6401264Jan 1, 1983Paper

Transplantation: immunogenetic and clinical aspects--part II

Hospital Practice
T B Strom, C B Carpenter

Abstract

The ultimate goal is not merely to find a better way of treating acute rejection; efforts are now concentrated on prophylactic immunosuppression with low-dose regimens of azathioprine and steroids. In the wings is cyclosporine, a fungal polypeptide that shows great promise in clinical trials. And on the horizon there is hope that monoclonal antibodies may hold the key to prevention.

Citations

Sep 1, 1988·Current Problems in Surgery·J G Copeland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Related Papers

Pediatric Clinics of North America
Michael Green, Steven Webber
Seminars in Liver Disease
Ryutaro Hirose, Flavio Vincenti
Current Opinion in Oncology
Asher Chanan-Khan, Myron S Czuczman
© 2021 Meta ULC. All rights reserved